Factors Associated with Late Initiation of Highly Active Antiretroviral Therapy among Young HIV-Positive Men and Women Aged 18 to 29 Years in Canada | Zendy

Alexis Palmer | Zendy; Angela Cescon | Zendy; Keith Chan | Zendy; Curtis Cooper | Zendy; Janet Raboud | Zendy; Caroline Miller | Zendy; Ann N. Burchell | Zendy; Marina B. Klein | Zendy; Nimâ Machouf | Zendy; Julio Montaner | Zendy; Chris Tsoukas | Zendy; Robert S. Hogg | Zendy; Mona Loutfy | Zendy

Open Access

Factors Associated with Late Initiation of Highly Active Antiretroviral Therapy among Young HIV-Positive Men and Women Aged 18 to 29 Years in Canada

Author(s) -

Alexis Palmer,

Angela Cescon,

Keith Chan,

Curtis Cooper,

Janet Raboud,

Caroline Miller,

Ann N. Burchell,

Marina B. Klein,

Nimâ Machouf,

Julio Montaner,

Chris Tsoukas,

Robert S. Hogg,

Mona Loutfy

Publication year - 2013

Publication title -

journal of the international association of providers of aids care (jiapac)

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.813

H-Index - 31

eISSN - 2325-9582

pISSN - 2325-9574

DOI - 10.1177/2325957413510606

Subject(s) - interquartile range , medicine , antiretroviral therapy , logistic regression , cohort , cohort study , human immunodeficiency virus (hiv) , young adult , demography , observational study , viral load , pediatrics , immunology , sociology

Initiating highly active antiretroviral therapy (HAART) with low CD4 counts or AIDS-defining illnesses (ADIs) increases risk of treatment failure and death. We examined factors associated with late initiation among 18- to 29-year-olds within the Canadian Observational Cohort (CANOC) collaboration, a multi-site study of HIV-positive persons who initiated HAART after 2000. Late initiation was defined as beginning HAART with a CD4 count 25 years at initiation, initiating treatment in earlier years, and having higher baseline viral load. The high number of young adults in our cohort starting HAART late indicates important target populations for specialized services, increased testing, and linkages to care.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research